Question 1

What is the analyst consensus rating for QNCX?

Accepted Answer

The analyst consensus rating for QNCX is "Hold" based on 2 analyst recommendations.

Question 2

What is the average price target for QNCX?

Accepted Answer

The average 12-month price target for QNCX is $not available.

Question 3

What do analyst ratings mean?

Accepted Answer

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

Question 4

What is a price target?

Accepted Answer

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.

Date	Analyst	Firm	Action	Rating	Price Target
Jan 30, 2026	Jason Kolbert	D Boral Capital	Downgrades	Hold	-
Jan 30, 2026	Jonathan Wolleben	Citizens	Downgrades	Hold	-
Jan 29, 2026	Jason Kolbert	D Boral Capital	Maintains	Strong Buy	$5.00 → $5.00 +0.00 (0.0%)
Dec 15, 2025	Jason Kolbert	D Boral Capital	Maintains	Strong Buy	$4.00 → $5.00 +1.00 (25.0%)

Quince Therapeutics (QNCX) Stock Analyst Forecast

Analyst Consensus Rating

Consensus Rating

Latest QNCX Analyst Ratings & Recommendations